Specific patterns of brain atrophy may be helpful in the diagnosis of Alzheimer's disease (AD). In the present study, we set out to evaluate the utility of grey-matter volume in the classification of AD and amnestic mild cognitive impairment (aMCI) compared to normal control (NC) individuals. Voxel-based morphometric analyses were performed on structural MRIs from 35 AD patients, 27 aMCI patients, and 27 NC participants. A two-sample two-tailed t-test was computed between the NC and AD groups to create a map of abnormal grey matter in AD. The brain areas with signifi cant differences were extracted as regions of interest (ROIs), and the grey-matter volumes in the ROIs of the aMCI patients were included to evaluate the patterns of change across different disease severities. Next, correlation analyses between the grey-matter volumes in the ROIs and all clinical variables were performed in aMCI and AD patients to determine whether they varied with disease progression. The results revealed significantly decreased grey matter in the bilateral hippocampus/ parahippocampus, the bilateral superior/middle temporal gyri, and the right precuneus in AD patients.
INTRODUCTION
Alzheimer's disease (AD) is the most common form of dementia in the elderly. AD is a neurodegenerative disorder pathologically characterized by the presence of amyloid deposits and neurofibrillary tangles [1] . The manifestations are progressive impairment of cognitive function and behavior. Currently, there is no effective treatment for this disease. Mild cognitive impairment (MCI) is a syndrome that involves cognitive impairments greater than expected based on an individual's age and educational level but not severe enough to interfere with daily activities [2, 3] . Amnestic MCI (aMCI), a subtype of MCI, is characterized by mild memory impairments and clinically it frequently progresses into AD within a few years. Pathologically, aMCI is a prodromal stage of AD in the majority of cases observed at autopsy [4] [5] [6] [7] .
Currently, the diagnoses of AD and MCI are based on clinical presentation and psychological tests. However, the diagnosis of AD has lower sensitivity (~70%) and specifi city (<70%) than the gold-standard neuropathological diagnosis [8] . Therefore, numerous studies have been designed to search for biomarkers of AD and MCI [9, 10] , including cerebrospinal fluid (CSF) Aβ and total tau, and some imaging measures based on positron emission tomography and magnetic resonance imaging (MRI) [9, 11] .
In addition, a recent cross-sectional study based on the Alzheimer's Disease Neuroimaging Initiative dataset has demonstrated that grey-matter atrophy reflects clinicallydefi ned disease stages better than CSF biomarkers (such as Aβ and total tau) [12] .
The evolution of patterns of grey-matter atrophy can be traced with the voxel-based morphometric (VBM) method; this method is hypothesis-free, rapid, sensitive in terms of localizing small-scale regional differences in grey matter, and easy to implement [13] . It has been widely applied to the study of regional grey-matter alterations in various disorders [14] [15] [16] [17] [18] [19] [20] [21] . The medial temporal lobe (including the hippocampus and parahippocampus) most consistently exhibits decreased grey-matter volume in AD and MCI [12, 16, 17, [22] [23] [24] [25] [26] [27] [28] [29] [30] . Moreover, changes in greymatter volumes in the entorhinal area [24] , medial temporal lobe [22] , hippocampus [31] , and entorhinal area including the hippocampus and amygdala [25] have been reported to be candidate features of AD compared with normal controls (NCs). Nevertheless, heterogeneous grey-matter atrophy patterns have been reported in AD and MCI [32, 33] , and few studies have investigated the ability of grey-matter volumes to discriminate between AD, MCI, and NC.
In this study, we focused on three questions: (1) where and how grey matter volumes are altered in Chinese AD patients compared to NCs; (2) whether aMCI patients exhibit AD-like changes in the identified regions; and (3) whether grey matter volumes discriminate AD/aMCI patients from NCs.
PARTICIPANTS AND METHODS
Portions of the fMRI data in the present study have been used in our previous studies of regional homogeneity [34] , and (4) Parkinsonian syndromes, epilepsy, or other nervous system diseases that can influence cognitive function.
Moreover, any participant with a metallic foreign body, such as a cochlear implant or heart stent, and any participant with any contraindication for MR scanning was excluded.
Data Acquisition
Sagittal structural images with a resolution of 0.94 × 0.94 × 1.2 mm 3 were acquired using a three-dimensional magnetization-prepared rapid gradient echo with a 3.0 T GE MR system (GE Healthcare, Milwaukee, WI) using a standard head coil. The scanning parameters were as follows: repetition time, 2 000 ms; echo time, 2.6 ms; and fl ip angle, 9 o . During the MRI scans, all participants were instructed to relax and move as little as possible. Tight but comfortable foam padding was used to reduce head motion, and earplugs were used to minimize scanner noise.
Data Preprocessing
Structural data were processed using Statistical Parametric Next, further analyses were performed on the grey-matter, white-matter, and CSF images, which were multiplied by the determinant of the Jacobian transform matrix for the non-linear component of the transformation to preserve the actual, local grey-matter and white-matter volumes (i.e., the modulated grey/white-matter volumes). Finally, the modulated grey-matter volumes were re-sliced to 2 × 2 × 2 mm 3 and smoothed with 6 mm at full width and half maximum Gaussian kernel [29] .
Statistical Analysis
To avoid possible white-matter/CSF effects, we introduced 
RESULTS

Group Differences in Grey-matter Volume
In AD patients, the regions with significantly decreased grey-matter volumes compared to NCs included the bilateral hippocampus/parahippocampus (Hip/Phip), the bilateral superior/middle temporal gyri (STG/MTG) and the right precuneus (Pcu) ( Table 2 and Fig. 1 ). In addition, the grey-matter volumes in the identified regions were decreased in the aMCI patients relative to the NCs (P < 0.05, FDR-corrected) (Fig. 2) . Furthermore, the grey-matter volumes in the bilateral Hip/Phip and bilateral STG/MTG were lower in the AD than in the aMCI patients (P <0.05, FDR-corrected) (Fig. 2) .
Whole-brain voxel-wise analyses revealed no signifi cant differences between the NC and aMCI groups or between the aMCI and AD groups at the threshold of P <0.05 (FWEcorrected). However, with a more relaxed threshold of P <0.001, cluster size >40 voxels (uncorrected), similar patterns of grey matter change were found in the aMCI and AD groups when compared to the NC group (Fig. S1 ).
Relationships between Grey-matter Volume and Clinical
Variables
In the aMCI plus AD group, the grey-matter volumes of all identifi ed regions exhibited signifi cant correlations with the MMSE and AVLT delayed-recall scores (Table 3 , Fig. 3 A, B) ; the grey-matter volumes of all identifi ed regions except the right precuneus exhibited significant correlations with the new word recognition scores (P <0.05) ( Table 3 , Fig. 3D ).
In the aMCI group, the grey-matter volumes of the bilateral Hip/Phip and the left STG/MTG showed signifi cant correlations with the AVLT delayed-recall and new word recognition scores (Table 3 , Fig. 3B, D) . The grey-matter volumes of the right STG/MTG were signifi cantly correlated with the AVLT immediate-recall scores (Table 3 , Fig. 3C ).
Exploratory Classifi cation Analyses
The grey matter of the bilateral Hip/Phip showed the most severe atrophy in the AD group ( Figs. 1 and 2) , which is consistent with most previous studies [16, 17, 23, 24] . To evaluate the potential use of grey-matter volumes for diagnosis, the bilateral Hip/Phip in the AAL template were selected using the WFU_PickAtlas toolkit (www.ansir.wfubmc.edu) [39] .
As different parts of the hippocampus play different roles in memory [40] and the head and tail are most severely impaired in AD [19, 41] , we further divided each hippocampus and parahippocampus into four subregions: the head, parts 1 and 2 of the body, and the tail (Fig. S2) . Thus 16 features for each participant were used in the discriminative and cross-validation analyses. Next, Fisher's linear discriminative method (see Appendix) and leave-one-out cross-validation analyses were performed to assess the utility of grey-matter volumes to classify patients [41] [42] [43] [44] . We also randomly left 2 to 5 participants out and re-performed the cross-validation analyses to test the robustness of the classification. The results revealed ~82% accuracy in discriminating AD patients from NC participants (Table 4 , Fig. 4A, Fig. S3 ). And ~58% of the cases were correctly classifi ed when the same protocol was used to distinguish all three groups (Table 5 , Fig. 4B, Fig. S4 ).
DISCUSSION
Grey-matter Atrophy in AD/aMCI
In the present study, the most marked atrophy of g r e y m a t t e r i n A D w a s i n t h e h i p p o c a m p u s a n d parahippocampus, regions that have been most consistently reported to exhibit signifi cant reductions in grey matter in AD [16, 17, [22] [23] [24] [25] [26] [27] [28] [29] . Previous histopathological studies have shown that the hippocampus and parahippocampus are the fi rst regions to be affected by neurofi brillary tangles Table 2 . and amyloid plaques, and also exhibit the greatest loss of neurons in AD [45, 46] . Furthermore, the positive correlations between grey-matter volumes and clinical variables (Fig. 3) provided evidence that grey-matter atrophy in the Hip/Phip may be helpful in AD diagnosis, and this was subsequently confirmed with the discriminative analyses (Tables 4   and 5 , Fig. 4 ). Providing further support for the present results, signifi cantly decreased grey-matter volumes in the STG/MTG and precuneus in AD have also been widely reported [16, 17, 23, [26] [27] [28] . Atrophy of grey matter in these regions also supports previous fi ndings that the initial pathological changes in AD occur in the medial temporal lobe and then spread to the other temporal lobe regions [45, 47] .
The major manifestation of aMCI is memory impairment, and because aMCI has a high risk of progression to AD, it is considered a prodromal stage [2, 4] .
In this study, the medial locations of the identifi ed regions of grey matter in the aMCI patients partially reflected this transitional stage (Fig. 2, Fig. S1 ). In addition, the significant alterations in the bilateral Hip/Phip and STG/ MTG between each pair of the three groups suggested that intense pathological changes occur in these regions throughout the development of AD.
Correlation of Grey-matter Volumes with Clinical Variables
Interestingly, grey-matter volumes in the identifi ed regions were significantly correlated with the neuropsychological test scores (Table 3, Fig. 3 ). The MMSE is a brief screening tool that quantitatively assesses the severity of cognitive impairment and reflects cognitive changes that occur during the progression of AD [48] . aMCI is an early symptomatic stage of AD [7, 49, 50] . However, the correlations between grey-matter volumes and clinical variables in some of the identifi ed regions in the aMCI or AD group were weak or absent (Table 3 , Fig. 3) . Therefore, the correlations may only be indicative of the general relationship between grey-matter atrophy and cognitive performance in the AD and aMCI patients and may have been influenced by group effects because not all aMCI patients convert to AD.
Is Grey-matter Atrophy Useful for Distinguishing between AD and MCI?
From a clinical perspective, the ultimate goal of the present study was to find biomarkers capable of discriminating patients from NCs. Although the pathophysiological processes of AD far precede the diagnosis [50] [51] [52] , here we found that grey-matter volumes have the potential to be used to identify AD (>82% of cases were correctly classified in the cross-validation tests) ( Table 4 , Fig. 4A , Fig. S3 ), consistent with many previous studies [25, 31, 53] .
However, the same analysis protocol did not perform well (~58% of cases were correctly identified in the crossvalidation tests) when the aMCI patients were included (Table 5 , Fig. 4B, Fig. S4 ). Several reasons may account for this decrease: whether and when aMCI patients convert to AD are uncertain [4, 7, [54] [55] [56] ; the AD patients in the present study were at a relatively mild stage (25 patients CDR = 1; 10 patients CDR = 2), which indicated an overlap in greymatter atrophy between the AD and aMCI groups (Fig.   2) ; and the pathological changes that underlie cognitive loss in patients with AD might emerge 10-20 years before symptoms of dementia [57] , implying that some of the NCs might have been in the preclinical stage of AD. Therefore, combinations of biomarkers and large samples are needed in the future.
Methodological Issues and Discussion of Comparisons
The patterns of grey-matter atrophy observed in the present study are in accord with previous findings; however, our results of whole brain voxel-wise analyses did not reveal signifi cant differences between the NC and aMCI groups or between the aMCI and AD groups at the threshold of P <0.05 (FWE-corrected). Nevertheless, the atrophy patterns of aMCI and AD were similar when a less strict threshold was used [P <0.001, cluster size >40 voxels (uncorrected) (Fig. S1) , which indicated that aMCI may be a prodromal stage of AD and that more severe symptoms are accompanied by more severe grey-matter atrophy (Fig. S1) . In contrast, it should also be noted that there was a trend toward statistical significance in age and gender among the NC, aMCI, and AD participants. Further analyses revealed similar patterns of grey-matter atrophy in AD regardless of whether age and gender were controlled for (Table S1 , Fig.   S5 ). Furthermore, we still do not have consistent criteria regarding the parcellation of the bilateral hippocampus and parahippocampus [58, 59] brains. In addition, there may be registration errors in the spatial normalization step. Moreover, image smoothing with a Gaussian fi lter kernel (kernel = 6 mm in the present study)
is necessary to make the data more normally distributed for statistical analysis; this process may lead to problems in localizing between-group volumetric differences in some of the smaller brain areas [61] [62] [63] .
SUPPLEMENTAL DATA
Supplemental data include fi ve fi gures and one table and can be found online at http://www.neurosci.cn/epData. asp?id=181.
APPENDIX. Fisher's Linear Discriminant Analysis
(FLDA) for Multiple Classes [44, 64] The primary goal of FLDA is to discriminate samples of different groups by maximizing the ratio of between-class separability to within-class variability. Suppose that we have K classes C k , and x is the feature; we need to fi nd a projection w and transform the feature to y. In the simplest case, the model is linear in the input variables and therefore takes the form so that y is a real number. According to Bayes' theorem, we can adopt a generative approach in which we model the class-conditional densities given by , together with the prior probabilities for the classes. We can then compute the required posterior probabilities using .
Theoretically, the within-class covariance matrix is where and is the probability for y belonging to class K. Then, we have which is known as the normalized exponential and can be regarded as a multiclass generalization of the logistic sigmoid. If , i=1,2..K, i≠j, then we can identify x to the jth class.
